Altre lingue Guangzhou Wondfo Biotech Co.,Ltd

Azioni

300482

CNE100002102

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 21/06/2024			Variaz. 5gg	Var. 1 gen.
26,39 ^CNY	+0,34%		-3,47%	-12,53%

06/05	L'unità di Wondfo Biotech ottiene l'autorizzazione all'uso di emergenza dalla FDA statunitense	MT
21/04	Guangzhou Wondfo Biotech Co.,Ltd riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Guangzhou Wondfo Biotech Co.,Ltd Announces Final Cash Dividend (A Shares) for Year 2023, Payable on June 5, 2024	29/05
Wondfo Biotech's Unit Gets Emergency Use Authorization from US FDA	06/05
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	21/04
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	15/08/23
Tranche Update on Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback Plan announced on July 5, 2023.	12/07/23
Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback announced on July 5, 2023 has closed with 1,121,900 shares, representing 0.25% for CNY 30.1 million.	11/07/23
Guangzhou Wondfo Biotech Co.,Ltd announces an Equity Buyback for CNY 50 million worth of its shares.	05/07/23
Guangzhou Wondfo Biotech Co.,Ltd authorizes a Buyback Plan.	05/07/23
Beijing PolySeq Technology Co., Ltd. announced that it has received CNY 100 million in funding from Guangzhou Wondfo Biotech Co.,Ltd, Guangzhou Sanmei Investment Management Center (Limited Partnership), Shangshi Capital, IDG Capital Partners Co., Ltd., Tsinghua Innovation Ventures	12/05/23
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23
Guangzhou Wondfo Biotech Co.,Ltd Approves the Cash Dividend for the Year 2022, Payable on 18 May 2023	24/04/23
Announcement on Resolutions of the 2022 Annual General Meeting of Guangzhou Wondfo Biotech	21/04/23
Guangzhou Huiyin Tianyue Nominates Mr.Ge Xinhua as Supervisor	10/04/23
Guangzhou Wondfo Biotech Co.,Ltd Proposes Final Cash Dividend for the Year 2022	31/03/23
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23
Beijing PolySeq Technology Co., Ltd. announced that it expects to receive CNY 40 million in funding from Guangzhou Wondfo Biotech Co.,Ltd, Guangzhou Sanmei Investment Management Center (Limited Partnership), Shangshi Capital, IDG Capital Partners Co., Ltd., Tsinghua Innovation Ventures	20/03/23
Investors bet on greed and fear as China loosens COVID grip	09/12/22
Guangzhou Wondfo Biotech Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22
Tranche Update on Guangzhou Wondfo Biotech Co.,Ltd's Equity Buyback Plan announced on September 26, 2022.	12/10/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Guangzhou Wondfo Biotech Co.,Ltd

Azioni

300482

CNE100002102

Altre lingue

Filtri